-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2023.
- KalVista Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending July 31, 2023 was -$26.7 M, a 17.5% decline year-over-year.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$75.3 M, a 3.68% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$78.1 M, a 159% decline from 2020.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$30.2 M, a 32.7% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)